Travere Therapeutics, Inc.

TVTX · Healthcare

$65.71

Markedsværdi: 6.19B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Travere Therapeutics, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Insider Monkey4. sep. 2026, 10.44

Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book

Investor's Business Daily24. aug. 2026, 16.56

TGTX Stock Outperforms 95% of Stocks. Here's Why.

Investor's Business Daily21. aug. 2026, 17.09

IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?'

Investor's Business Daily21. aug. 2026, 16.09

Three Biotech Stocks Stick Out With Their Stellar Charts

MarketBeat18. aug. 2026, 10.01

Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipeline